SOURCE: MDwerks

August 04, 2006 08:00 ET

MDwerks Poised for Significant Sustainable Growth, Says Cohen Independent Research Report

In-Depth Report Values Company Stock at 68.6% Higher Than Current Market Price

DEERFIELD BEACH, FL -- (MARKET WIRE) -- August 4, 2006 -- MDwerks, Inc. (OTCBB: MDWK), a provider of innovative Web-based, electronic claims management and funding solutions for healthcare professionals, "is on the threshold of a significant and sustainable growth phase," concluded a paid independent 68-page research report published by Cohen Independent Research Group on July 20, 2006.

"At the current market price of $4.05 per share, MDwerks is undervalued," the report stated. "Even our most conservative [analysis] yielded a value of $6.58-$7.12 per share, which is 68.6% higher than the current market price at the mid-level of our target price range."

The full report can be obtained free of charge from the home page of the Cohen Independent Research Group's Web site at www.cohenresearch.com.

In addition to addressing the large and growing healthcare industry, the report stated, MDwerks benefits from several other "value drivers," including:

--  The Company's unique plug-and-play, end-to-end solution for all the
    operational and cash flow management problems of healthcare service
    providers;
    
--  The scalable business model that addresses the needs of all types of
    healthcare providers and gives huge scope for the Company's future
    expansion;
    
--  First-mover advantage, and
    
--  A robust revenue model that establishes income from four sources that
    are increasing in scale and volume.
    
On page 63, the report states that MDwerks paid Cohen Independent Research Group $10,000 in cash and 25,000 shares for a one-year period to conduct the research and publish the report.

"We are extremely pleased with this thoughtful report," said Howard Katz, CEO of MDwerks. "It provides an in-depth analysis of our current business and growth strategy which will be highly informative to our current shareholders and all others who follow innovative companies addressing the healthcare sector. Our technology and solutions are indeed unique. Our patent-pending one-stop system automates HIPAA-compliant claims management and facilitates advance funding for healthcare professionals and lenders. The plug-and-play technology requires no purchase of hardware or software. We developed our system over a five-year period using strategic resources such as IBM Global System and Arthur Anderson, as well as large 'brand name' financial institutions and medical insurance companies. Increasing numbers of doctors and other providers are finding that MDwerks solutions greatly improve their administrative efficiency and financial control, giving them more time and ability to serve their patients well."

About Cohen Independent Research Group

The Cohen Independent Research Group is a registered California Investment Advisor. The firm's purpose is to distribute unbiased fundamental research reports. It selects micro cap stocks, small cap stocks and mid cap emerging companies with management teams focused on shareholder value, sustainable competitive advantage, and companies that demonstrate market leadership in their respective disciplines. The Group's independent research includes investment research, company research, business research and quantitative research. Investment research includes biotech, pharmaceutical, technology and other industry groups. For full information and recent research reports, please go to www.cohenresearch.com.

About MDwerks, Inc.

MDwerks, Inc. (OTCBB: MDWK), based in Deerfield Beach, Florida, provides healthcare professionals with automated electronic insurance claims management solutions and advance funding of medical claims, as submitted, through a revolving line of credit. MDwerks™ solutions comprise an innovative Web-based, HIPAA-compliant system of comprehensive administrative and financial services designed for physician practices of all sizes and specialties whether in a single or multi-location operation. Financial lenders, healthcare payers and other related business, including mobile diagnostic companies, billing companies and clearinghouses, also benefit from MDwerks solutions. For more information about the Company, please visit www.mdwerks.com.

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things, the following: general economic and business conditions; competition; unexpected changes in technologies and technological advances; ability to commercialize and manufacture products; results of experimental studies; research and development activities; changes in, or failure to comply with, governmental regulations; and the ability to obtain adequate financing in the future. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of MDwerks' Securities and Exchange Commission filings available at http://www.sec.gov.

Pursuant to a December 1, 2005 agreement, Consulting For Strategic Growth 1, Ltd. ("CFSG1") provides MDwerks, Inc. with consulting, business advisory, investor relations, public relations and corporate development services, for which CFSG1 receives a fixed monthly fee for the duration of the agreement. Independent of CFSG1's receipt of cash compensation from MDwerks, CFSG1 may choose to purchase the common stock of MDwerks and thereafter sell those shares at any time it deems appropriate to do so. For more information, go to www.cfsg1.com.

Contact Information

  • CONTACTS:

    Vincent Colangelo
    Chief Financial Officer
    MDwerks, Inc.
    Tel: 954-389-8300
    Fax: 954-427-5871
    Email: Email Contact

    Stanley Wunderlich
    Chief Executive Officer
    Consulting for Strategic Growth 1
    Tel: 800-625-2236
    Fax: 212-337-8089
    Email: Email Contact

    Daniel Stepanek
    Media Relations
    Consulting for Strategic Growth 1
    Tel: 212-896-1202
    Fax: 212-697-0910
    Email: Email Contact